Yongfeng Li

Title: Yongfeng Li: Innovator in Pharmaceutical Nanotechnology

Introduction

Yongfeng Li is a notable inventor based in Hebei, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative therapeutic nanoparticles. With a total of 3 patents to his name, Li's work is paving the way for advancements in drug delivery systems.

Latest Patents

Li's latest patents include a liposome that features an inner water phase containing sulfobutyl ether cyclodextrin salt. This liposome comprises a bilayer and an inner water phase that may contain both sulfobutyl ether cyclodextrin and an active compound. Another significant patent involves purified therapeutic nanoparticles, which consist of an active pharmaceutical ingredient and human serum albumin. The weight ratio of human serum albumin to the active ingredient in these nanoparticles ranges from 0.01:1 to 1:1. Importantly, these nanoparticles are designed to be substantially free of any free human serum albumin that is not incorporated within them. The patent also outlines methods for preparing and utilizing these purified therapeutic nanoparticles and their associated pharmaceutical compositions.

Career Highlights

Yongfeng Li has worked with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. and Cspc Zhongqi Pharmaceutical Technology Co., Ltd. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of cutting-edge technologies.

Collaborations

Li has collaborated with notable colleagues such as Chunlei Li and Caixia Wang. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Yongfeng Li is a distinguished inventor whose work in pharmaceutical nanotechnology is making a significant impact. His innovative patents and collaborations reflect his commitment to advancing drug delivery systems.